This register starts on September 20, 2026. It contains no reconstructed predictions or retrospective success scores. “Observing” means the test is open; it does not mean the claim has been confirmed.
A longer useful life can soften accounting expense while cash investment stays high
Observing · Recorded September 20, 2026 · Next review December 20, 2026
Capital spending and depreciation are different measurements. An accounting estimate can change expense without changing the purchase price of an asset. The question we will test is whether subsequent company disclosures show that divergence—not whether a simple model proves any particular company is understating costs. Our scenario tool demonstrates the arithmetic; company filings must supply the evidence. No historical score is assigned at launch.
Evidence that would support it
A subsequent filing explicitly quantifies lower depreciation from a useful-life extension, while its comparable company-wide cash property-and-equipment purchases remain above the prior-year period. Evaluate each company separately.
Evidence that would challenge it
A reported shortening of useful lives with higher depreciation, or lower comparable cash purchases, contradicts that combination for that company and period. Without a quantified accounting effect, mark insufficient evidence.
Evidence to follow
Review history
No subsequent review yet. The original statement above is the launch baseline.
Return to the dossierRefinancing can lift the note stock’s average rate without a fresh policy-rate rise
Observing · Recorded September 20, 2026 · Next review December 20, 2026
Outstanding notes retain their coupons until maturity. Replacing a low-coupon note at a higher yield can therefore lift the average even if the overnight policy rate is unchanged. This is a conditional mechanism with an explicit observation window, not a prediction of the federal deficit. The Data Note supplies the baseline; new observations will be evaluated without changing this original statement.
Evidence that would support it
Compare each available month through November 2026 with August 2026: a rise in the average note rate alongside an unchanged or lower policy target supports the proposed refinancing mechanism. Inspect issuance yields before attributing the cause.
Evidence that would challenge it
A flat or declining average note rate over that window would not support the expected upward repricing in this window. A policy-rate rise makes the specific unchanged-policy test inconclusive.
Evidence to follow
Review history
No subsequent review yet. The original statement above is the launch baseline.
Return to the dossier